Scores by echosens
Enhance FibroScan® liver disease assessment with biological markers
Learn more
FibroScan® probes
Because each patient has a different morphology, choose the appropriated FibroScan® S+, M+ or XL+ probe to get the best FibroScan® performance.
Optimize measurement accuracy
FibroScan® offers a range of 3 probes (S+, M+ and XL+) designed to fit patient morphology.
By adjusting the measurement area relative to the distance between the probe and the liver (Probe to Capsula Distance) a consistent explored volume can be maintained.
For M+ and XL+ probes, FibroScan® automatically recommends the right probe.
Which FibroScan® probe is adapted to your patient?
|
FibroScan® S+ Probe |
FibroScan® M+ Probe |
FibroScan® XL+ Probe |
|
For thin patients Designed for being placed into narrow intercostal space |
For standard morphotype’s patients |
For overweight patients Designed to enhance signal penetration through deeper tissues |
|
Measurement depth From 15 to 50 mm |
Measurement depth From 25 to 65 mm From 25 to 70 mm with SmartExam |
Measurement depth From 35 to 75 mm From 35 to 85 mm with SmartExam |
|
Criteria of selection Age < 18yo and Thoracic Perimeter ≤ 75 cm
|
Criteria of selection Age < 18yo and or |
Criteria of selection Age ≥ 18yo and no M+ probe recommendation |
FibroScan® comes with the standard FibroScan® M+ probe.
FibroScan® S+ and FibroScan® XL+ probes are available as an option.
Probes selection criteria
To ensure that the probe is adapted to the patient’s morphology, please read the FibroScan® examination procedure.
What our users say
The obese population that we receive for FibroScan® examinations has increased substantially in recent years. CAP™ has become essential to our prescribers to precisely monitor patient’s steatosis.
Probe calibration service
FibroScan® probe calibration is an essential maintenance service to guarantee the quality and reliability of your measurements.
FibroScan® Indications for Use
The FibroScan® family of products is intended to provide shear wave speed measurements and estimates of tissue stiffness as well as ultrasound coefficient of attenuation (CAP: Controlled Attenuation Parameter) in internal structures of the body. The Shear wave speed and stiffness measurements may be used as an aid to clinical management of adult patients with liver disease. The FibroScan® family of products is indicated for non-invasive measurement in the liver of 50 Hz shear wave speed and estimates of stiffness as well as determining a 3.5 MHz ultrasound coefficient of attenuation (CAP: Controlled Attenuation Parameter). The shear wave speed and stiffness, and CAP may be used as an aid to diagnosis and monitoring of adult patients with liver disease, as part of an overall assessment of the liver. Shear wave speed and stiffness, and CAP* may be used as an aid in the clinical management of pediatric patients with liver disease. The FibroScan® 630 (Expert) is also indicated for noninvasive measurement in the spleen of 100 Hz shear wave speed and estimates of stiffness that may be used as an aid to diagnosis, monitoring and clinical management of adult patients with liver disease, as part of an overall assessment of the liver.
* CAP for pediatric patients with liver disease is only available with SmartExam capability.